Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Cell Res ; 313(14): 3026-33, 2007 Aug 15.
Article in English | MEDLINE | ID: mdl-17574237

ABSTRACT

RNA polymerase II transcribes most eukaryotic genes. Photobleaching studies have revealed that living Chinese hamster ovary cells expressing the catalytic subunit of the polymerase tagged with the green fluorescent protein contain a large rapidly exchanging pool of enzyme, plus a smaller engaged fraction; genetic complementation shows this tagged polymerase to be fully functional. We investigated how transcriptional inhibitors--some of which are used therapeutically--affect the engaged fraction in living cells using fluorescence loss in photobleaching; all were used at concentrations that have reversible effects. Various kinase inhibitors (roscovitine, DRB, KM05283, alsterpaullone, isoquinolinesulfonamide derivatives H-7, H-8, H-89, H-9), proteasomal inhibitors (lactacystin, MG132), and an anti-tumour agent (cisplatin) all reduced the engaged fraction; an intercalator (actinomycin D), two histone deacetylase inhibitors (trichostatin A, sodium butyrate), and irradiation with ultra-violet light all increased it. The polymerase proves to be both a sensitive sensor and effector of the response to these inhibitors.


Subject(s)
Enzyme Inhibitors/metabolism , Photobleaching , Protein Subunits/metabolism , RNA Polymerase II , Transcription, Genetic , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/metabolism , Animals , Benzazepines/metabolism , Cell Line , Cisplatin/metabolism , Cricetinae , Cricetulus , Cross-Linking Reagents/metabolism , Dactinomycin/metabolism , Female , Histone Deacetylase Inhibitors , Histone Deacetylases/metabolism , Indoles/metabolism , Proteasome Endopeptidase Complex/metabolism , Proteasome Inhibitors , Protein Subunits/genetics , Protein Synthesis Inhibitors/metabolism , RNA Polymerase II/antagonists & inhibitors , RNA Polymerase II/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Ultraviolet Rays
2.
Biochem Soc Symp ; (73): 67-75, 2006.
Article in English | MEDLINE | ID: mdl-16626288

ABSTRACT

We have previously suggested a model for the eukaryotic genome based on the structure of the bacterial nucleoid where active RNA polymerases cluster to loop the intervening DNA. This organization of polymerases into clusters--which we call transcription 'factories'--has important consequences. For example, in the nucleus of a HeLa cell the concentration of soluble RNA polymerase II is approximately 1 mM, but the local concentration in a factory is 1000-fold higher. Because a promoter can diffuse approximately 100 nm in 15 s, one lying near a factory is likely to initiate; moreover, when released at termination, it will still lie near a factory, and the movement and modifications (e.g. acetylation) accompanying elongation will leave it in an 'open' conformation. Another promoter out in a long loop is less likely to initiate, because the promoter concentration falls off with the cube of the distance from the factory. Moreover, a long tether will buffer it from transcription-induced movement, making it prone to deacetylation, deposition of HP1 (heterochromatin protein 1), and incorporation into heterochromatin. The context around a promoter will then be self-sustaining: productive collisions of an active promoter with the factory will attract factors increasing the frequency of initiation, and the longer an inactive promoter remains inactive, the more it becomes embedded in heterochromatin. We review here the evidence that different factories may specialize in the transcription of different groups of genes.


Subject(s)
Transcription, Genetic , Bacteria/genetics , Bacteria/metabolism , Cell Nucleolus/genetics , Cell Nucleolus/metabolism , DNA/genetics , DNA/metabolism , Eukaryotic Cells , Globins/genetics , HeLa Cells , Heterochromatin/genetics , Heterochromatin/metabolism , Humans , Models, Genetic , Promoter Regions, Genetic , RNA Polymerase II/metabolism , RNA Polymerase III/metabolism
3.
J Mol Biol ; 333(1): 87-102, 2003 Oct 10.
Article in English | MEDLINE | ID: mdl-14516745

ABSTRACT

Our previous studies on the human MEN1 (multiple endocrine neoplasia type 1) gene revealed heterogeneity of MEN1 2.8 kb transcripts related to variation in their 5' UTR only. Six distinct exons 1 (e1A-e1F) were isolated that suggested the existence of multiple but not already identified transcriptional start sites (TSS) and of a complex transcriptional control. Identification of a minimal promoter region and its adjacent regulatory regions appears an inescapable step to the understanding of MEN1 gene transcriptional regulation in normal and pathological situations. For this purpose, we subcloned the approximately 2000 bp region situated directly upstream of the exon 2 in front of a luciferase reporter gene, and we analyzed functional consequences of 5' and 3' serial deletions, comparatively in a series of endocrine versus non-endocrine cell lines. Primer extension and RPA experiments demonstrate that in HEK293 cells transcription initiated simultaneously at several points in endogenous MEN1 promoter as well as in transfected promoter fragments in reporter plasmids, mainly in Inr elements that are efficiently employed to synthetize previously described exons e1A-e1D. Functional consequences of TSS deletion are directly related to cellular context. The minimal promoter region is localized between -135 and -36. Five large adjacent cis-regulatory regions (UR1-UR5) exist upstream of this minimal promoter region, whose activity depend not only on the cellular context but also on the presence of a downstream sequence DR1. Five small cis-regulatory elements (C1-C5) are localized between -325 and -107. Overexpression of exogenous menin, the MEN1 gene's product, in mouse embryonic fibroblasts from Men1(-/-) knock-out mice dose-dependently decreases MEN1 promoter activity, through sequences surrounding the minimal promoter. Our data highlight the existence of a complex transcriptional regulation of the MEN1 gene, whose activity is clearly modulated depending not only on the cellular context but also on menin intracellular levels. They are the molecular bases required for a future understanding of a potential specific transcription control in endocrine cells.


Subject(s)
Gene Expression Regulation , Neoplasm Proteins/genetics , Promoter Regions, Genetic , Proto-Oncogene Proteins , Base Sequence , Humans , Molecular Sequence Data , Sequence Analysis, DNA , Sequence Deletion
4.
J Clin Endocrinol Metab ; 88(8): 3845-51, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12915678

ABSTRACT

Multiple endocrine neoplasia type I (MEN1) is an autosomal dominant tumor syndrome, with the presence of tumors in parathyroid, pancreatic, and anterior pituitary. The tumor suppressor gene MEN1, located on chromosome 11q13, encodes a 610 amino acid, 68-kDa protein, menin. Menin is conserved among species but has no similarity with any known protein. To investigate how the expression is regulated in both man and mouse, we assayed a greater than 1-kb region upstream of the second exon for promoter activity in luciferase reporter vectors. The basic promoter was located closely upstream the most commonly expressed first exon. The region further upstream modified the activity. Repetitive elements of the short interspersed/Alu type covered the entire human upstream regulatory region and were the only apparent motif in common with its murine ortholog. Previous studies have indicated a compensatory induction of the second allele because of inactivation of the first allele. We found that overexpression of menin in an inducible cell culture system down-regulated the proximal promoter. In response to down-regulation of MEN1 expression by RNA interference, the regulatory region activated the promoter in a compensatory manner. Our data confirm that the expression of the MEN1 gene is regulated by a feedback from its product menin.


Subject(s)
Gene Expression Regulation, Neoplastic/genetics , Multiple Endocrine Neoplasia Type 1/genetics , Proto-Oncogene Proteins , Transcription, Genetic/genetics , 3T3 Cells , 5' Flanking Region/genetics , Animals , Cell Line , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Down-Regulation/genetics , Humans , Mice , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Nuclease Protection Assays , Plasmids/genetics , Promoter Regions, Genetic/genetics , RNA Interference/physiology , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...